Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

A plant‐derived edible vaccine against hepatitis B virus

Józef KapustaInstitute of Bioorganic Chemistry of the Polish Academy of Sciences Poznan PolandA. ModelskaBiotechnology Foundation Laboratories Thomas Jefferson University Philadelphia Pennsylvania 19107 USAMagdalena FiglerowiczMarcinkovski Academy of Medical Sciences Department of Pediatric Poznan PolandTomasz PniewskiInstitute of Bioorganic Chemistry of the Polish Academy of Sciences Poznan PolandMarie-Claude LetellierInstitute of Bioorganic Chemistry of the Polish Academy of Sciences Poznan PolandO. LisowaInstitute of Bioorganic Chemistry of the Polish Academy of Sciences Poznan PolandVidadi YusibovBiotechnology Foundation Laboratories Thomas Jefferson University Philadelphia Pennsylvania 19107 USAHilary KoprowskiBiotechnology Foundation Laboratories Thomas Jefferson University Philadelphia Pennsylvania 19107 USAAndrzej PłucienniczakInstitute of Biotechnology and Antibiotics Warsaw PolandAndrzej B. LegockiInstitute of Bioorganic Chemistry of the Polish Academy of Sciences Poznan Poland
1999en
ABI

Аннотация

ABSTRACT The infectious hepatitis B virus represents 42 nm spherical double‐shelled particles. However, analysis of blood from hepatitis B virus carriers revealed the presence of smaller 22 nm particles consisting of a viral envelope surface protein. These particles are highly immunogenic and have been used in the design of hepatitis B virus vaccine produced in yeast. Upon expression in yeast, these proteins form virus‐like particles that are used for parenteral immunization. Therefore, the DNA fragment encoding hepatitis B virus surface antigen was introduced into Agrobacterium tumerifacience LBA4404 and used to obtain transgenic lupin ( Lupinus luteus L .) and lettuce ( Lactuca sativa L .) cv. Burpee Bibb expressing envelope surface protein. Mice that were fed the transgenic lupin tissue developed significant levels of hepatitis B virus‐specific antibodies. Human volunteers, fed with transgenic lettuce plants expressing hepatitis B virus surface antigen, developed specific serum‐IgG response to plant produced protein.—Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., Legocki, A. B. A plant‐derived edible vaccine against hepatitis B virus. FASEB J . 13, 1796–1799 (1999)

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0